Novo Nordisk ADR (NVO) Stock: Navigating Market Highs and Lows in 52 Weeks

VIPS stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Novo Nordisk ADR’s current trading price is -1.52% away from its 52-week high, while its distance from the 52-week low is 87.59%. The stock’s price range for this period has been between $75.56 and $143.94 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.32 million for the day, a number notably lower than the average daily volume of 3.93 million over the last three months.

Novo Nordisk ADR saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $143.94 on 06/10/24, while the lowest price for the same duration was marked at $75.56 on 07/11/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Novo Nordisk ADR (NVO) has experienced a quarterly rise of 4.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 473.21B and boasts a workforce of 63370 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 126.21, with a change in price of +34.10. Similarly, Novo Nordisk ADR recorded 4,604,592 in trading volume during the last 100 days, posting a change of +31.71%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NVO stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.17.

NVO Stock Stochastic Average

As of today, Novo Nordisk ADR’s raw stochastic average for the last 50 days stands at 89.89%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 82.51%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 91.57% and 93.97%, respectively.

NVO Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 37.02% this year. Over the last six months, there has been a weaker performance of 46.67%. The price of NVO fallen by 10.38% during the last 30 days period. For the last 5-days stocks have improved 1.30%.

Most Popular